NewLink Genetics Corporation
34 clinical trials · Sponsor
◉ Watch NewLink Genetics Corporation
| Record | Firm | Date |
|---|---|---|
| Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers (NCT03852446) | NewLink Genetics Corporation | 2018-03-05 |
| A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma (NCT03301636) | NewLink Genetics Corporation | 2017-12-08 |
| Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers (NCT03372239) | NewLink Genetics Corporation | 2017-11-21 |
| Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy (NCT03165188) | NewLink Genetics Corporation | 2017-09-01 |
Track NewLink Genetics Corporation automatically
Every clearance here is in the API, with alerts when new ones post.